CORC

在结果中检索

CORC

浏览/检索结果: 共26条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载：29/0  |  提交时间：2022/12/22
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation 期刊论文
ONCOGENE, 2020, 卷号: 39
作者:  Jin, Ying;  Bao, Hua;  Le, Xiuning;  Fan, Xiaojun;  Tang, Ming
收藏  |  浏览/下载：25/0  |  提交时间：2020/11/26
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 8, 页码: 3898-3923
作者:  Liang, Xuewu;  Zang, Jie;  Li, Xiaoyang;  Tang, Shuai;  Huang, Min
收藏  |  浏览/下载：18/0  |  提交时间：2020/07/01
The Co-Occurring Genomic Landscape of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 10, 页码: S412-S412
作者:  Yuan, B.;  Zhao, J.;  Zhou, C.;  Wang, X.;  Zhu, B.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/11
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12, 页码: 8311-8318
作者:  An, Ning;  Wang, Haoyi;  Li, Ji;  Zhai, Xiaoyang;  Jing, Wang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/11
Concurrent Presence of ALK Rearrangement and MET Mutation in Lung Adenocarcinoma 期刊论文
2019, 卷号: 14, 期号: 2, 页码: E42-E44
作者:  Qiu, Tian;  Zhang, Fanshuang;  Li, Weihua;  Guo, Lei;  Ying, Jianming
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Low expression of aging-related NRXN3 is associated with Alzheimer disease A systematic review and meta-analysis 期刊论文
Medicine, 2018, 卷号: 97, 期号: 28, 页码: e11343
作者:  Jun-Juan Zheng, PhD;  Jing-Fei Huang, PhD;  Jia-Qian Liu, PhD;  Yi-Cheng Guo, PhD;  Qian Wang, PhD
收藏  |  浏览/下载：39/0  |  提交时间：2018/09/29
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Propofol inhibits hERG K+ channels and enhances the inhibition effects on its mutations in HEK293 cells 期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 卷号: 791, 页码: 168-178
作者:  Han, Sheng-Na;  Jing, Ying;  Yang, Lin-Lin;  Zhang, Zhao;  Zhang, Li-Rong
收藏  |  浏览/下载：42/0  |  提交时间：2019/01/08
Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family 期刊论文
CANCER BIOLOGY & THERAPY, 2016
Yuan, Ping; Sun, Qipeng; Liang, Hao; Wang, Wenjun; Li, Ling; Wang, Ye; Deng, Huan; Lai, Luhua; Chen, Xiaoli; Zhou, Xiangfu
收藏  |  浏览/下载：2/0  |  提交时间：2017/12/03

©版权所有 ©2017 CSpace - Powered by CSpace